Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4IDS6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.481 |
CLV_NRD_NRD_1 | 197 | 199 | PF00675 | 0.512 |
CLV_NRD_NRD_1 | 368 | 370 | PF00675 | 0.722 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.487 |
CLV_PCSK_FUR_1 | 76 | 80 | PF00082 | 0.501 |
CLV_PCSK_KEX2_1 | 197 | 199 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 368 | 370 | PF00082 | 0.722 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.495 |
CLV_PCSK_PC1ET2_1 | 345 | 347 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 249 | 253 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 300 | 304 | PF00082 | 0.644 |
CLV_PCSK_SKI1_1 | 368 | 372 | PF00082 | 0.594 |
DEG_SPOP_SBC_1 | 150 | 154 | PF00917 | 0.559 |
DOC_CYCLIN_RxL_1 | 297 | 304 | PF00134 | 0.485 |
DOC_PP4_FxxP_1 | 139 | 142 | PF00568 | 0.605 |
DOC_USP7_MATH_1 | 132 | 136 | PF00917 | 0.582 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.537 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.473 |
DOC_USP7_UBL2_3 | 114 | 118 | PF12436 | 0.481 |
DOC_USP7_UBL2_3 | 265 | 269 | PF12436 | 0.524 |
DOC_WW_Pin1_4 | 130 | 135 | PF00397 | 0.632 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.525 |
LIG_14-3-3_CanoR_1 | 8 | 16 | PF00244 | 0.675 |
LIG_14-3-3_CanoR_1 | 89 | 95 | PF00244 | 0.462 |
LIG_Actin_WH2_2 | 101 | 119 | PF00022 | 0.457 |
LIG_APCC_ABBA_1 | 170 | 175 | PF00400 | 0.357 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.677 |
LIG_FHA_1 | 217 | 223 | PF00498 | 0.448 |
LIG_FHA_1 | 284 | 290 | PF00498 | 0.451 |
LIG_FHA_1 | 355 | 361 | PF00498 | 0.470 |
LIG_FHA_1 | 369 | 375 | PF00498 | 0.549 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.437 |
LIG_FHA_2 | 49 | 55 | PF00498 | 0.613 |
LIG_LIR_Apic_2 | 137 | 142 | PF02991 | 0.608 |
LIG_LIR_Gen_1 | 107 | 116 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 175 | 184 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 330 | 340 | PF02991 | 0.465 |
LIG_LIR_Gen_1 | 50 | 59 | PF02991 | 0.686 |
LIG_LIR_Nem_3 | 107 | 112 | PF02991 | 0.591 |
LIG_LIR_Nem_3 | 175 | 181 | PF02991 | 0.408 |
LIG_LIR_Nem_3 | 330 | 336 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.721 |
LIG_PCNA_yPIPBox_3 | 174 | 185 | PF02747 | 0.529 |
LIG_Pex14_2 | 49 | 53 | PF04695 | 0.655 |
LIG_PTAP_UEV_1 | 380 | 385 | PF05743 | 0.626 |
LIG_SH2_CRK | 178 | 182 | PF00017 | 0.382 |
LIG_SH2_STAP1 | 178 | 182 | PF00017 | 0.413 |
LIG_SH2_STAT3 | 184 | 187 | PF00017 | 0.420 |
LIG_SH3_3 | 378 | 384 | PF00018 | 0.626 |
LIG_TRAF2_1 | 243 | 246 | PF00917 | 0.436 |
LIG_TRAF2_1 | 61 | 64 | PF00917 | 0.665 |
MOD_CDK_SPxxK_3 | 69 | 76 | PF00069 | 0.512 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.690 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.529 |
MOD_CK1_1 | 301 | 307 | PF00069 | 0.473 |
MOD_CK1_1 | 359 | 365 | PF00069 | 0.534 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.796 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.676 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.461 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.531 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.761 |
MOD_CK2_1 | 346 | 352 | PF00069 | 0.529 |
MOD_CK2_1 | 48 | 54 | PF00069 | 0.662 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.682 |
MOD_CK2_1 | 68 | 74 | PF00069 | 0.577 |
MOD_Cter_Amidation | 195 | 198 | PF01082 | 0.438 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.651 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.583 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.644 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.548 |
MOD_GlcNHglycan | 290 | 293 | PF01048 | 0.470 |
MOD_GlcNHglycan | 303 | 306 | PF01048 | 0.414 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.625 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.592 |
MOD_GSK3_1 | 375 | 382 | PF00069 | 0.598 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.601 |
MOD_N-GLC_1 | 4 | 9 | PF02516 | 0.616 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.528 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.587 |
MOD_NEK2_1 | 375 | 380 | PF00069 | 0.543 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.598 |
MOD_PIKK_1 | 283 | 289 | PF00454 | 0.438 |
MOD_PKA_1 | 368 | 374 | PF00069 | 0.604 |
MOD_PKA_2 | 258 | 264 | PF00069 | 0.498 |
MOD_PKA_2 | 368 | 374 | PF00069 | 0.604 |
MOD_PKA_2 | 7 | 13 | PF00069 | 0.676 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.373 |
MOD_Plk_4 | 90 | 96 | PF00069 | 0.466 |
MOD_ProDKin_1 | 130 | 136 | PF00069 | 0.635 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.517 |
MOD_SUMO_rev_2 | 257 | 264 | PF00179 | 0.500 |
TRG_AP2beta_CARGO_1 | 50 | 60 | PF09066 | 0.628 |
TRG_DiLeu_BaLyEn_6 | 27 | 32 | PF01217 | 0.528 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.426 |
TRG_ENDOCYTIC_2 | 178 | 181 | PF00928 | 0.413 |
TRG_ER_diArg_1 | 197 | 199 | PF00400 | 0.423 |
TRG_ER_diArg_1 | 367 | 369 | PF00400 | 0.715 |
TRG_ER_diArg_1 | 75 | 78 | PF00400 | 0.491 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBK9 | Leptomonas seymouri | 39% | 100% |
A0A3Q8ILJ1 | Leishmania donovani | 99% | 100% |
A4HQ19 | Leishmania braziliensis | 68% | 100% |
E9ATT7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4Q0Q9 | Leishmania major | 91% | 100% |